| ²é¿´: 1083 | »Ø¸´: 1 | |||
¹þ¹þ¹þxcгæ (³õÈëÎÄ̳)
|
[½»Á÷]
½á¹¹ÉúÎïѧÉ격 ÒÑÓÐ1È˲ÎÓë
|
|
±¾ÈËÑÐÈý£¬ÎÂÖÝÒ½¿Æ´óѧ&걽ʵÑéÊÒÁªºÏÅàÑø£¬Ê¦´ÓÓÚMoosa Mohammadi½ÌÊÚ£¨ÃÀ¹úŦԼ´óѧµ°°×½á¹¹ÖÐÐÄÊ×ϯ¿ÆÑ§¼Ò¡¢ê±½ÊµÑéÊÒϸ°ûÉú³¤Òò×ÓÑо¿ÖÐÐÄÖ÷ÈΣ©£¬Ë¶Ê¿Ñо¿·½ÏòΪÅÔ·ÖÃÚÉú³¤Òò×Ó¼°ÆäÊÜÌåµÄ½á¹¹Ó빦ÄÜÑо¿¡£ ??±¾È˾ßÓÐÉϺ£ÏßÕ¾ÑÜÉä¾§ÌåºÍÊÕ¼¯Êý¾Ý¾Ñ飬ĿǰʵÑéÊÒÒÑÅ䱸300KVÀä¶³µç¾µ£¬ÕýÔÚÉÏÊÖÀä¶³ÖÆÑùºÍ¸ºÈ¾¡£ ??˶ʿѧϰÆÚ¼ä³¤ÆÚͨ¹ý´ó³¦¸Ë¾ú£¨¿ÉÈÜÐԺͰüºÌ壩ºÍ²¸È鶯Îïϸ°ûHek293ϸ°ûϵ±í´ï²¢´¿»¯µ°°× ??ĿǰÒÔ¹²Ò»µÄÉí·Ý¡¶Design of a FGF23 partial agonist as a potential treatment for acute kidney injury without hypophosphatemia risk¡·Í¶¸åNature Communications¡£ ??¿ÆÑм¼ÄÜ·½Ã棬ÊìÁ·Ê¹ÓÃAKTAµ°°×´¿»¯ÒÇ¡¢Sec-Mals¡¢SPRÒÇ¡¢µ°°×½á¾§µãÑù»úÆ÷ÈËÒÔ¼°ÊìÁ·ÕÆÎÕDNA ºÍRNAÌáÈ¡¡¢Ï¸°ûÅàÑø¡¢PEIתȾ¡¢SDS-PAGE¡¢WB¡¢ELISA¡¢PCR¡¢ÃâÒß×黯µÈÏà¹ØÊµÑé²Ù×÷¡£ ??ÒÑͨ¹ýÓ¢ÓïÁù¼¶£¬Ë¶Ê¿Ñ§Ï°ÆÚ¼ä»ñµÃУ¼¶¶þµÈ½±Ñ§½ð¡¢Ð£¼¶ÈýµÈ½±Ñ§½ð¡£ Ï£ÍûÄÜÕÒµ½½á¹¹ÉúÎïѧ·½ÏòµÄ²©µ¼£¡ ·¢×ÔСľ³æIOS¿Í»§¶Ë |
» ²ÂÄãϲ»¶
323Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
Ò»Ö¾Ô¸±±¾©»¯¹¤´óѧ 070300 ѧ˶ 336·Ö Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
352Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
Ò»Ö¾Ô¸¶«»ª´óѧ»¯Ñ§070300£¬Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
277²ÄÁÏ¿ÆÑ§Ó빤³Ì080500Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
317Çóµ÷¼Á
ÒѾÓÐ18È˻ظ´
293Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
280·ÖÇóµ÷¼Á Ò»Ö¾Ô¸085802
ÒѾÓÐ7È˻ظ´
0854µç×ÓÐÅÏ¢Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
263Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
ÎÞÉùʤÓÐÉù
Òø³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 1128.1
- É¢½ð: 276
- Ìû×Ó: 187
- ÔÚÏß: 137.9Сʱ
- ³æºÅ: 3762106
- ×¢²á: 2015-03-24
- ÐÔ±ð: GG
- רҵ: °ëµ¼Ìå²ÄÁÏ

2Â¥2025-01-13 15:17:11













»Ø¸´´ËÂ¥